KDM5C
Basic information
Region (hg38): X:53176277-53225422
Previous symbols: [ "SMCX", "JARID1C", "MRX13" ]
Links
Phenotypes
GenCC
Source:
- syndromic X-linked intellectual disability Claes-Jensen type (Definitive), mode of inheritance: XLR
- syndromic X-linked intellectual disability Claes-Jensen type (Supportive), mode of inheritance: XL
- syndromic X-linked intellectual disability Claes-Jensen type (Definitive), mode of inheritance: XL
- syndromic X-linked intellectual disability Claes-Jensen type (Strong), mode of inheritance: XL
- X-linked syndromic intellectual disability (Definitive), mode of inheritance: XL
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Intellectual developmental disorder, X-linked, syndromic, Claes-Jensen type | XL | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Craniofacial; Genitourinary; Musculoskeletal; Neurologic | 10982473; 15586325; 16538222; 18697827; 18203167; 19826449; 21575681; 22326837; 22611640 |
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (35 variants)
- Syndromic X-linked intellectual disability Claes-Jensen type (24 variants)
- Spastic paraplegia (16 variants)
- Inborn genetic diseases (10 variants)
- Intellectual disability (4 variants)
- Rare genetic intellectual disability (1 variants)
- Developmental disorder (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the KDM5C gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 138 | 25 | 167 | |||
missense | 23 | 211 | 25 | 13 | 279 | |
nonsense | 32 | 38 | ||||
start loss | 1 | |||||
frameshift | 33 | 41 | ||||
inframe indel | 8 | |||||
splice donor/acceptor (+/-2bp) | 13 | 17 | ||||
splice region | 13 | 11 | 3 | 27 | ||
non coding | 63 | 30 | 101 | |||
Total | 75 | 50 | 233 | 226 | 68 |
Highest pathogenic variant AF is 0.00000898
Variants in KDM5C
This is a list of pathogenic ClinVar variants found in the KDM5C region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
X-53191607-T-C | Uncertain significance (Oct 01, 2023) | |||
X-53192476-G-A | Likely benign (Dec 17, 2018) | |||
X-53192587-C-T | Likely benign (Oct 10, 2019) | |||
X-53192606-G-T | Likely benign (Jul 27, 2018) | |||
X-53192769-G-T | Uncertain significance (Feb 01, 2017) | |||
X-53192774-C-G | Likely benign (Oct 01, 2024) | |||
X-53192818-A-G | not specified | Uncertain significance (Sep 27, 2024) | ||
X-53192834-A-T | KDM5C-related disorder | Likely benign (Feb 08, 2024) | ||
X-53192835-G-C | not specified | not provided (Sep 19, 2013) | ||
X-53192837-G-C | Uncertain significance (Feb 01, 2019) | |||
X-53192837-G-T | KDM5C-related disorder | Likely benign (Jul 01, 2023) | ||
X-53192838-G-A | Syndromic X-linked intellectual disability Claes-Jensen type | Uncertain significance (Apr 27, 2019) | ||
X-53192843-C-G | KDM5C-related disorder • Inborn genetic diseases | Conflicting classifications of pathogenicity (Dec 20, 2023) | ||
X-53192843-C-T | Likely benign (Jan 21, 2021) | |||
X-53192858-GCCACCCCCCTACCCGC-G | Benign (Dec 05, 2018) | |||
X-53192861-A-AC | Benign (Jul 03, 2018) | |||
X-53192868-T-C | Benign (Mar 28, 2020) | |||
X-53192869-A-C | Benign (Mar 29, 2020) | |||
X-53192873-G-C | Likely benign (Aug 17, 2018) | |||
X-53192881-C-T | Likely benign (Dec 17, 2018) | |||
X-53192924-C-T | Benign (Apr 09, 2021) | |||
X-53192975-G-C | Uncertain significance (May 28, 2019) | |||
X-53192975-G-T | Likely benign (Oct 01, 2024) | |||
X-53192976-T-C | Uncertain significance (Dec 07, 2017) | |||
X-53192985-C-T | Spastic paraplegia • Inborn genetic diseases | Likely benign (Aug 04, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
KDM5C | protein_coding | protein_coding | ENST00000375401 | 26 | 34102 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.00 | 0.00000147 | 125742 | 1 | 4 | 125747 | 0.0000199 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 5.15 | 293 | 667 | 0.439 | 0.0000572 | 10067 |
Missense in Polyphen | 43 | 263.2 | 0.16337 | 4170 | ||
Synonymous | -0.582 | 272 | 260 | 1.05 | 0.0000201 | 3210 |
Loss of Function | 6.38 | 4 | 55.1 | 0.0726 | 0.00000433 | 846 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000760 | 0.0000615 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000128 | 0.00000879 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.000158 | 0.0000980 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Histone demethylase that specifically demethylates 'Lys- 4' of histone H3, thereby playing a central role in histone code (PubMed:28262558). Does not demethylate histone H3 'Lys-9', H3 'Lys-27', H3 'Lys-36', H3 'Lys-79' or H4 'Lys-20'. Demethylates trimethylated and dimethylated but not monomethylated H3 'Lys-4'. Participates in transcriptional repression of neuronal genes by recruiting histone deacetylases and REST at neuron-restrictive silencer elements. Represses the CLOCK-ARNTL/BMAL1 heterodimer- mediated transcriptional activation of the core clock component PER2 (By similarity). {ECO:0000250|UniProtKB:P41230, ECO:0000269|PubMed:17320160, ECO:0000269|PubMed:17320161, ECO:0000269|PubMed:17468742, ECO:0000269|PubMed:26645689, ECO:0000269|PubMed:28262558}.;
- Disease
- DISEASE: Mental retardation, X-linked, syndromic, Claes-Jensen type (MRXSCJ) [MIM:300534]: A disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. MRXSCJ patients manifest mental retardation associated with variable features such as slowly progressive spastic paraplegia, seizures, facial dysmorphism. {ECO:0000269|PubMed:15586325, ECO:0000269|PubMed:16538222, ECO:0000269|PubMed:16541399, ECO:0000269|PubMed:17320160, ECO:0000269|PubMed:17468742, ECO:0000269|PubMed:23356856, ECO:0000269|PubMed:25666439}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Pathways in clear cell renal cell carcinoma;HDMs demethylate histones;Chromatin modifying enzymes;Chromatin organization
(Consensus)
Recessive Scores
- pRec
- 0.193
Intolerance Scores
- loftool
- 0.0636
- rvis_EVS
- -1.51
- rvis_percentile_EVS
- 3.5
Haploinsufficiency Scores
- pHI
- 0.235
- hipred
- Y
- hipred_score
- 0.839
- ghis
- 0.527
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.730
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Kdm5c
- Phenotype
- integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); growth/size/body region phenotype; homeostasis/metabolism phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); embryo phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); normal phenotype; hematopoietic system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan);
Zebrafish Information Network
- Gene name
- kdm5c
- Affected structure
- whole organism
- Phenotype tag
- abnormal
- Phenotype quality
- curved ventral
Gene ontology
- Biological process
- negative regulation of transcription by RNA polymerase II;chromatin remodeling;histone H3-K4 demethylation;histone H3-K4 demethylation, trimethyl-H3-K4-specific;negative regulation of transcription, DNA-templated;rhythmic process;oxidation-reduction process
- Cellular component
- nucleus;nucleoplasm;cytosol;histone methyltransferase complex
- Molecular function
- DNA-binding transcription factor activity, RNA polymerase II-specific;DNA binding;protein binding;zinc ion binding;histone demethylase activity;histone demethylase activity (H3-K4 specific);histone demethylase activity (H3-trimethyl-K4 specific);dioxygenase activity